Eli Lilly Raises Forecasts with Diabetes Drug Mounjaro's Strong Performance

Australia News News

Eli Lilly Raises Forecasts with Diabetes Drug Mounjaro's Strong Performance
Australia Latest News,Australia Headlines
  • 📰 Investingcom
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 53%

⚠️BREAKING: *ELI LILLY EXTENDS RALLY TO 17%, TOPS $500 BILLION MARKET VALUE $LLY

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: Only post material that’s relevant to the topic being discussed. Avoid profanity, slander or personal attacks

directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Investingcom /  🏆 450. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Morgan Stanley predicts Eli Lilly shares to rally on Novo's obesity drug dataMorgan Stanley predicts Eli Lilly shares to rally on Novo's obesity drug dataMorgan Stanley believes that the positive data on Novo Nordisk's obesity drug Wegovy will also benefit Eli Lilly, leading to a potential increase in its stock value. Novo Nordisk's shares surged by 15% following the release of late-stage trial data, which demonstrated that Wegovy reduced the risk of major cardiovascular events by 20% compared to a placebo.
Read more »

Ozempic and Mounjaro makers sued by patient alleging ‘severe gastrointestinal issues'Ozempic and Mounjaro makers sued by patient alleging ‘severe gastrointestinal issues'The medications are used to treat Type 2 diabetes and have become popular weight-loss drugs.
Read more »

Patient Sues Ozempic and Mounjaro Makers Over Severe Gastrointestinal IssuesPatient Sues Ozempic and Mounjaro Makers Over Severe Gastrointestinal IssuesA patient from Louisiana has filed a lawsuit against Novo Nordisk, the maker of Ozempic, and Eli Lilly, the maker of Mounjaro, alleging that they failed to adequately warn about the potential adverse side effects of the medications, including the risk of gastroparesis.
Read more »

Eli McCann: Welcome to a Big Fat Mormon Wedding — where cousins arrive by the dozensEli McCann: Welcome to a Big Fat Mormon Wedding — where cousins arrive by the dozensSalt Lake Tribune guest columnist Eli McCann talks about large Latter-day Saint families and their big, yet not-so-big, weddings.
Read more »

Dolphins’ Tyreek Hill excited to ‘embarrass’ Eli Apple at practice as they squash beefDolphins’ Tyreek Hill excited to ‘embarrass’ Eli Apple at practice as they squash beefApparently, when it comes to the perceived beef between Tyreek Hill and Eli Apple, the former thinks people read too much into their social media interactions.
Read more »

Missouri's Eli Drinkwitz wonders if anyone has thought about student-athletes amid conference realignmentsMissouri's Eli Drinkwitz wonders if anyone has thought about student-athletes amid conference realignmentsMissouri football coach Eli Drinkwitz opened up Saturday about the college sports shake-up and wondered if anyone has thought about the kids.
Read more »



Render Time: 2025-02-27 11:52:45